Concurrent Investment Advisors LLC Buys 26,925 Shares of Ventas, Inc. $VTR

Key Points

• Concurrent Investment Advisors LLC increased its Ventas stake by 737.3% in the second quarter, purchasing 26,925 additional shares for a total holding of 30,577 shares valued at approximately $2.7 million.
• Analysts remain broadly positive on Ventas, with 14 Buy ratings and three Holds producing a “Moderate Buy” consensus and an average price target of $99; several firms recently raised targets to as high as $110.
• Ventas exceeded quarterly expectations, reporting $0.97 in earnings per share versus a $0.96 estimate and $1.73 billion in revenue, up 21.7% year over year.

Concurrent Investment Advisors LLC lifted its stake in Ventas, Inc. (NYSE:VTR - Free Report) by 737.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 30,577 shares of the real estate investment trust's stock after purchasing an additional 26,925 shares during the quarter. Concurrent Investment Advisors LLC's holdings in Ventas were worth $2,715,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Dynamic Wealth Strategies LLC purchased a new position in Ventas during the first quarter worth $25,000. Wiser Advisor Group LLC purchased a new stake in shares of Ventas in the third quarter valued at $27,000. Silvant Capital Management LLC purchased a new stake in shares of Ventas in the second quarter valued at $28,000. Meeder Asset Management Inc. bought a new stake in shares of Ventas in the 2nd quarter worth about $30,000. Finally, IFC & Insurance Marketing Inc. bought a new stake in shares of Ventas in the 4th quarter worth about $30,000. Institutional investors own 94.18% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on VTR. BMO Capital Markets upped their price target on shares of Ventas from $105.00 to $107.00 and gave the company an "outperform" rating in a report on Tuesday, August 11th. Weiss Ratings raised shares of Ventas from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Tuesday, July 21st. Citigroup boosted their target price on Ventas from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Tuesday, August 4th. The Goldman Sachs Group reaffirmed a "buy" rating and set a $110.00 target price on shares of Ventas in a research note on Tuesday, May 19th. Finally, Raymond James Financial began coverage on Ventas in a report on Tuesday, June 16th. They issued an "outperform" rating and a $94.00 price target on the stock. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, Ventas presently has a consensus rating of "Moderate Buy" and an average target price of $99.00.

Ventas Price Performance

Ventas stock opened at $89.94 on Wednesday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The stock has a market cap of $46.13 billion, a price-to-earnings ratio of 166.55, a price-to-earnings-growth ratio of 3.52 and a beta of 0.70. The firm has a 50-day moving average of $92.99 and a two-hundred day moving average of $87.89. Ventas, Inc. has a 1 year low of $66.54 and a 1 year high of $101.60.

Ventas (NYSE:VTR - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.01. The firm had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company's revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.87 earnings per share. On average, research analysts forecast that Ventas, Inc. will post 3.89 earnings per share for the current year.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.